spacer
home > ict > autumn 2017 > important choices
PUBLICATIONS
International Clinical Trials

Important Choices

Although underrated, site selection is one of the most
significant processes for a successful trial. A recent report
suggests that 50% of sites under-enrol and 11% fail to register
a single patient in a given trial (1). Therefore, the process of
choosing locations is one of the most critical tasks in clinical
development, as picking the right one can significantly affect
study outcomes, time savings and overall expenditure.

Making the choice once the study or protocol design is clear is
best practice, as this ensures that comprehensive information
about the patient population, investigator specialities, personnel
and necessary equipment is available. This enables a strong
understanding on the types of challenges encounterable
through the site selection process, and having this information
upfront can help CROs and sponsors put the right strategies
in place (2).

The fundaments for a good selection plan are a combination
of picking high-quality and high-performing locations globally,
identifying efficiencies and strengths and optimising the use
of clinical technologies that produce real time access to data.
One of the first steps is to define the requirements, resources
and qualifications necessary for a given trial

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bandana Seesurn is Lead Project Manager at CIDP. She works with cross-functional teams to identify client needs and develop solutions for projects, leveraging expertise and operational capabilities. In her role, Bandana manages the full scope of trial set-up and conduct, from protocol, site selection and budgeting to regulatory submissions, project development, data management and reporting. She has acquired expertise in feasibility studies, site qualification and management, human and financial resource management and regulatory affairs. She has a bachelor’s degree in biomedical science and a master’s degree in pharmaceutical science with management studies from Kingston University London, UK.
spacer
Bandana Seesurn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Language Weaver now available for ServiceNow customers

RWS, the world’s leading provider of technology-enabled language, content management, and intellectual property services, has released a new Language Weaver Connector for ServiceNow
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement